Paul A. Friedman
2018 - Synta Pharmaceuticals
In 2018, Paul A. Friedman earned a total compensation of $5.6M as Chairman and Chief Executive Officer at Synta Pharmaceuticals, a 312% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $304,500 |
|---|---|
| Option Awards | $4,907,500 |
| Salary | $416,666 |
| Total | $5,628,666 |
Friedman received $4.9M in option awards, accounting for 87% of the total pay in 2018.
Friedman also received $304.5K in non-equity incentive plan and $416.7K in salary.
Rankings
In 2018, Paul A. Friedman's compensation ranked 1,718th out of 14,244 executives tracked by ExecPay. In other words, Friedman earned more than 87.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,718 out of 14,244 | 88th |
Division Manufacturing | 611 out of 5,765 | 89th |
Major group Chemicals And Allied Products | 196 out of 2,128 | 91st |
Industry group Drugs | 156 out of 1,817 | 91st |
Industry Pharmaceutical Preparations | 116 out of 1,391 | 92nd |
Pay ratio
| Paul A. Friedman's Pay | $5,628,666 |
|---|---|
| Median Employee's Pay | $804,000 |
| Pay Ratio | 7to 1 |
In 2018, the annual total compensation of Paul A. Friedman was $5,628,666.
The annual total compensation of the median employee at Synta Pharmaceuticals was $804,000.
The ratio of Paul A. Friedman's pay to the pay of median employee was therefore 7 to one.
Source: SEC filing on May 15, 2019.
Friedman's colleagues
We found two more compensation records of executives who worked with Paul A. Friedman at Synta Pharmaceuticals in 2018.